...
首页> 外文期刊>Journal of Clinical Microbiology >Evaluation of the syphilis Bio-EnzaBead assay for detection of treponemal antibody.
【24h】

Evaluation of the syphilis Bio-EnzaBead assay for detection of treponemal antibody.

机译:梅毒Bio-EnzaBead分析检测用于检测螺旋体抗体的评估。

获取原文

摘要

An enzyme-linked immunosorbent assay for Treponema pallidum antibody (Syphilis Bio-EnzaBead Kit; Organon Teknika Corp., formerly Litton Bionetics, Kensington, Md.) was compared with the standard fluorescent treponemal antibody absorption test for syphilis (indirect fluorescent-antibody confirmatory test; Zeus Scientific Inc., Raritan, N.J.). Six hundred specimens tested in the rapid plasma Reagin card test (Hynson, Westcott and Dunning, Inc., Baltimore, Md.) and microhemagglutination assay for antibodies to T. pallidum (Ames Division, Miles Laboratories, Inc., Elkhart, Ind.) were used for comparison testing. One hundred and sixty-two specimens were from either persons with syphilis or persons whose history was unknown but who showed reactive serology, whereas 438 were from persons without syphilis. The reactivity of each serum by the Bio-EnzaBead test was determined visually and from optical density readings. Excellent reproducibility of visual readings was obtained; all results were within +/- 1 gradation of the expected readings in all 60 coded sera tested. Overall agreement between the Bio-EnzaBead and fluorescent treponemal antibody absorption test results was 96.3% when read visually and greater than or equal to 95.7% when using optical density readings. Our data indicate that Bio-EnzaBead results read at 405 nm and determined by using the mean antigen optical density reading of the nonreactive control plus 0.025 as the cutoff value provide an overall sensitivity and specificity of 93.0 and 98.6%, respectively, along with the best agreement with the fluorescent treponemal antibody absorption assay. Ease of performance and objectivity also contribute toward the acceptability of this assay as an alternative confirmatory test for syphilis.
机译:将梅毒螺旋体抗体的酶联免疫吸附测定法(Syphilis Bio-EnzaBead Kit; Organon Teknika Corp.,原名Litton Bionetics,Kensington,MD)与梅毒的标准荧光梅毒螺旋体抗体吸收测试(间接荧光抗体确证测试)进行了比较; Zeus Scientific Inc.,Raritan,NJ)。在快速血浆Reagin卡检测(马里兰州巴尔的摩的Hynson,Westcott和Dunning,Inc.)和微血凝试验中检测了600份标本,用于抗梅毒螺旋体的抗体(印第安纳州Elkhart的Miles Laboratories,Inc.的Ames Division)用于比较测试。 162份标本来自梅毒患者或病史未知但表现出反应性血清学的患者,而438份标本来自无梅毒患者。通过Bio-EnzaBead测试通过目视和从光密度读数确定每种血清的反应性。获得了极好的视觉读数再现性;在所有测试的60种编码血清中,所有结果均在预期读数的+/- 1级内。目视读取时,Bio-EnzaBead与荧光性视网膜色素上皮抗体吸收测试结果之间的总体一致性为96.3%,而使用光密度读数时则大于或等于95.7%。我们的数据表明,Bio-EnzaBead结果在405 nm处读取,并通过使用非反应性对照的平均抗原光密度读数加上0.025作为临界值来确定,分别提供了93.0和98.6%的总体灵敏度和特异性,以及最佳的与荧光性视网膜瘤抗体吸收试验一致。易用性和客观性也有助于这种测定方法作为梅毒的另一种验证性试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号